Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 48


Self-reported quality of life in multiple sclerosis patients: preliminary results based on the Polish MS Registry.

Brola W, Sobolewski P, Fudala M, Flaga S, Jantarski K, Ryglewicz D, Potemkowski A.

Patient Prefer Adherence. 2016 Aug 26;10:1647-56. doi: 10.2147/PPA.S109520. eCollection 2016.


Parental attitudes and aggression in the Emo subculture.

Chęć M, Potemkowski A, Wąsik M, Samochowiec A.

Psychiatr Pol. 2016;50(1):19-28. doi: 10.12740/PP/36316. English, Polish.


Prolonged-release oxycodone-naloxone for treatment of severe pain in patients with Parkinson's disease (PANDA): a double-blind, randomised, placebo-controlled trial.

Trenkwalder C, Chaudhuri KR, Martinez-Martin P, Rascol O, Ehret R, Vališ M, Sátori M, Krygowska-Wajs A, Marti MJ, Reimer K, Oksche A, Lomax M, DeCesare J, Hopp M; PANDA study group..

Lancet Neurol. 2015 Dec;14(12):1161-70. doi: 10.1016/S1474-4422(15)00243-4. Epub 2015 Oct 19.


Bioelectrical function and structural assessment of the retina in patients with early stages of Parkinson's disease (PD).

Nowacka B, Lubiński W, Honczarenko K, Potemkowski A, Safranow K.

Doc Ophthalmol. 2015 Oct;131(2):95-104. doi: 10.1007/s10633-015-9503-0. Epub 2015 May 14.


Effects of delayed-release dimethyl fumarate on MRI measures in the phase 3 CONFIRM study.

Miller DH, Fox RJ, Phillips JT, Hutchinson M, Havrdova E, Kita M, Wheeler-Kingshott CA, Tozer DJ, MacManus DG, Yousry TA, Goodsell M, Yang M, Zhang R, Viglietta V, Dawson KT; CONFIRM study investigators..

Neurology. 2015 Mar 17;84(11):1145-52. doi: 10.1212/WNL.0000000000001360. Epub 2015 Feb 13.


Ophthalmological features of Parkinson disease.

Nowacka B, Lubinski W, Honczarenko K, Potemkowski A, Safranow K.

Med Sci Monit. 2014 Nov 11;20:2243-9. doi: 10.12659/MSM.890861.


[Specificity of attention and cognitive inhibition processes in relapsing -remitting multiple sclerosis patients with consideration of their mood level].

Tyburski E, Potemkowski A, Cheć M, Sołtys A, Mak M, Samochowiec A.

Psychiatr Pol. 2014 Mar-Apr;48(2):307-18. Polish.


Pegylated interferon β-1a for relapsing-remitting multiple sclerosis (ADVANCE): a randomised, phase 3, double-blind study.

Calabresi PA, Kieseier BC, Arnold DL, Balcer LJ, Boyko A, Pelletier J, Liu S, Zhu Y, Seddighzadeh A, Hung S, Deykin A; ADVANCE Study Investigators..

Lancet Neurol. 2014 Jul;13(7):657-65. doi: 10.1016/S1474-4422(14)70068-7. Epub 2014 Apr 30.


Oral teriflunomide for patients with relapsing multiple sclerosis (TOWER): a randomised, double-blind, placebo-controlled, phase 3 trial.

Confavreux C, O'Connor P, Comi G, Freedman MS, Miller AE, Olsson TP, Wolinsky JS, Bagulho T, Delhay JL, Dukovic D, Truffinet P, Kappos L; TOWER Trial Group..

Lancet Neurol. 2014 Mar;13(3):247-56. doi: 10.1016/S1474-4422(13)70308-9. Epub 2014 Jan 23.


External support of a polytetrafluoroethylene graft improves patency for bypass to below-knee arteries.

Lundgren F; Swedish External Support Study (SWEXSUS)..

Ann Vasc Surg. 2013 Nov;27(8):1124-33. doi: 10.1016/j.avsg.2013.02.009. Epub 2013 Aug 20.


Placebo-controlled phase 3 study of oral BG-12 for relapsing multiple sclerosis.

Gold R, Kappos L, Arnold DL, Bar-Or A, Giovannoni G, Selmaj K, Tornatore C, Sweetser MT, Yang M, Sheikh SI, Dawson KT; DEFINE Study Investigators..

N Engl J Med. 2012 Sep 20;367(12):1098-107. Erratum in: N Engl J Med. 2012 Dec 13;367(24):2362.


Placebo-controlled phase 3 study of oral BG-12 or glatiramer in multiple sclerosis.

Fox RJ, Miller DH, Phillips JT, Hutchinson M, Havrdova E, Kita M, Yang M, Raghupathi K, Novas M, Sweetser MT, Viglietta V, Dawson KT; CONFIRM Study Investigators..

N Engl J Med. 2012 Sep 20;367(12):1087-97. Erratum in: N Engl J Med. 2012 Oct 25;367(17):1673.


Some dopaminergic genes polymorphisms are not associated with response to antipsychotic drugs in schizophrenic patients.

Tybura P, Samochowiec A, Beszlej A, Grzywacz A, Mak M, Frydecka D, Bieńkowski P, Mierzejewski P, Potemkowski A, Samochowiec J.

Pharmacol Rep. 2012;64(3):528-35.


Patient-reported quality of life in multiple sclerosis differs between cultures and countries: a cross-sectional Austrian-German-Polish study.

Pluta-Fuerst A, Petrovic K, Berger T, Fryze W, Fuchs S, Gold R, Kozubski W, Ladurner G, Petereit H, Potemkowski A, Rieckmann P, Sailer M, Szczudlik A, Vass K, Weber T, Zakrzewska-Pniewska B, Fazekas F.

Mult Scler. 2011 Apr;17(4):478-86. doi: 10.1177/1352458510391341. Epub 2010 Dec 9.


10-year stroke prevention after successful carotid endarterectomy for asymptomatic stenosis (ACST-1): a multicentre randomised trial.

Halliday A, Harrison M, Hayter E, Kong X, Mansfield A, Marro J, Pan H, Peto R, Potter J, Rahimi K, Rau A, Robertson S, Streifler J, Thomas D; Asymptomatic Carotid Surgery Trial (ACST) Collaborative Group..

Lancet. 2010 Sep 25;376(9746):1074-84. doi: 10.1016/S0140-6736(10)61197-X.


A double-blind, randomized, placebo and active-controlled study of nebicapone for the treatment of motor fluctuations in Parkinson's disease.

Ferreira JJ, Rascol O, Poewe W, Sampaio C, Rocha JF, Nunes T, Almeida L, Soares-da-Silva P; BIA-3202-202 Study Investigators..

CNS Neurosci Ther. 2010 Dec;16(6):337-47. doi: 10.1111/j.1755-5949.2010.00145.x.


Pattern electroretinogram (PERG) and pattern visual evoked potential (PVEP) in the early stages of Alzheimer's disease.

Krasodomska K, Lubiński W, Potemkowski A, Honczarenko K.

Doc Ophthalmol. 2010 Oct;121(2):111-21. doi: 10.1007/s10633-010-9238-x. Epub 2010 Jun 13.


PTFE bypass to below-knee arteries: distal vein collar or not? A prospective randomised multicentre study.


Eur J Vasc Endovasc Surg. 2010 Jun;39(6):747-54. doi: 10.1016/j.ejvs.2010.01.016. Epub 2010 Mar 16.


Endovascular aortic stent graft repair for blunt traumatic thoracic aortic transection.

Saleh A, Potemkowski A, Abu-Zidan FM.

Singapore Med J. 2008 Oct;49(10):847-8. No abstract available.

Supplemental Content

Loading ...
Support Center